Richard Korentager
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Richard Korentager has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
Elizabeth Muenks
From the Departments of Plastic Surgery, Psychiatry and Behavioral Sciences, and Population Health, University of Kansas Medical Center
3 shared publicationsMichelle De Souza
From the Departments of Plastic Surgery, Psychiatry and Behavioral Sciences, and Population Health, University of Kansas Medical Center
3 shared publications- Katie G. Egan
Division of Plastic and Reconstructive Surgery, Department of Surgery University of Colorado Anschutz Medical Campus Aurora Colorado USA
2 shared publications Niaman Nazir
Department of Population Health, University of Kansas Medical Center, Kansas City, Kansas, USA
2 shared publicationsAndrea L. Allen
Department of Plastic Surgery, University of Kansas Medical Center, Kansas City, Kansas, USA
1 shared publicationAshlie Elver
Department of Plastic Surgery, University of Kansas Medical Center, Kansas City, KS, United States
1 shared publication
Latest Publications
- Open Access
- 21 July 2025
- Published by Elsevier in Journal of Surgical Education
- Vol. 82 (9) , 103625
Tipping the Scales: Quantifying the Impact of USMLE Step 1 Pass/Fail Scoring on Application Interpretation in the Integrated Plastic Surgery Match
- 21 July 2025
- Published by Elsevier in Journal of Surgical Education
- Vol. 82 (9) , 103625
Open AccessTipping the Scales: Quantifying the Impact of USMLE Step 1 Pass/Fail Scoring on Application Interpretation in the Integrated Plastic Surgery Match
- Open Access
- 15 April 2022
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 9, 843793
Case Report: Idiopathic Subcutaneous Thrombotic Vasculopathy
Lower extremity ulcers have significant morbidity, with treatment determined by the underlying disorder. Reported is a 32-year-old female presenting with small skin nodules and bruises across her legs 4 weeks following her second COVID vaccination. These lesions progressed into large, necrotic ulcers over several months. Initial work-up showed widespread pannicular thrombotic vasculopathy with ischemic skin necrosis. The tissue was negative for calcification on Von Kossa histochemistry, and a working diagnosis of subcutaneous thrombotic vasculopathy was suggested. The ulcers progressed despite treatments with corticosteroids, therapeutic anticoagulation, intravenous immunoglobulin, plasmapheresis, sodium thiosulfate, wound care, and repeat debridement. Later debridement specimens demonstrated rare vascular and pannicular calcifications. This finding supports the hypothesis that subcutaneous thrombotic vasculopathy is a precursor to calciphylaxis, the patient’s current working diagnosis. However, based on the patient’s entire clinical picture, a definitive diagnosis has yet to be found. This report highlights the challenges of working with rare diseases and the importance of multidisciplinary cooperation.
- 15 April 2022
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 9, 843793
Open AccessCase Report: Idiopathic Subcutaneous Thrombotic Vasculopathy
Lower extremity ulcers have significant morbidity, with treatment determined by the underlying disorder. Reported is a 32-year-old female presenting with small skin nodules and bruises across her legs 4 weeks following her second COVID vaccination. These lesions progressed into large, necrotic ulcers over several months. Initial work-up showed widespread pannicular thrombotic vasculopathy with ischemic skin necrosis. The tissue was negative for calcification on Von Kossa histochemistry, and a working diagnosis of subcutaneous thrombotic vasculopathy was suggested. The ulcers progressed despite treatments with corticosteroids, therapeutic anticoagulation, intravenous immunoglobulin, plasmapheresis, sodium thiosulfate, wound care, and repeat debridement. Later debridement specimens demonstrated rare vascular and pannicular calcifications. This finding supports the hypothesis that subcutaneous thrombotic vasculopathy is a precursor to calciphylaxis, the patient’s current working diagnosis. However, based on the patient’s entire clinical picture, a definitive diagnosis has yet to be found. This report highlights the challenges of working with rare diseases and the importance of multidisciplinary cooperation.
- 1 October 2020
- Published by Wolters Kluwer Health in Plastic and Reconstructive Surgery
- Vol. 146 (4) , 734-741
Predictors of Opioid Consumption in Immediate, Implant-Based Breast Reconstruction
Background: Current rates of opioid prescribing have deleterious consequences on both patient and societal levels. This study aims to evaluate responsible opioid prescribing and predictors of opioid consumption in immediate implant-based breast reconstruction. Methods: Patients undergoing consultation for immediate, implant-based breast reconstruction were enrolled in a prospective, cohort survey study. A survey was administered at the preoperative and postoperative appointment to collect data on pain expectations and opioid use. A medical record review was performed. Results: Of 100 enrolled patients, 97 (97.0 percent) underwent surgery and 85 (85.0 percent) completed the postoperative survey. Preoperatively, 27 patients (27.0 percent) had a history of a chronic pain syndrome, 34 (34.0 percent) had a history of a mental health comorbidity, and nine (9.0 percent) had a history of active preoperative opioid use. A total of 85 tissue expander (87.6 percent) and 12 direct-to-implant (12.4 percent) reconstructions were completed. Patients were prescribed an average of 36.0 5-mg oxycodone tablets postoperatively. Patients reported consuming an average of 20.6 tablets, or 57.0 percent of the average prescription amount. The majority of patients (75.3 percent) reported taking an opioid less than once per day at the time of survey completion, and 24 patients (28.2 percent) reported that they did not use any opioids postoperatively. Preoperative opioid use (p= 0.004), inpatient opioid consumption (p< 0.0001), and patient-reported anxiety related to pain control (p< 0.05) were predictors of opioid consumption. Conclusions: Patients undergoing mastectomy and implant-based breast reconstruction are prescribed nearly twice as many opioid tablets as consumed, and one in three patients report not using any opioids postoperatively. Clinical factors may help guide prescribing practices.
- 1 October 2020
- Published by Wolters Kluwer Health in Plastic and Reconstructive Surgery
- Vol. 146 (4) , 734-741
Predictors of Opioid Consumption in Immediate, Implant-Based Breast Reconstruction
Background: Current rates of opioid prescribing have deleterious consequences on both patient and societal levels. This study aims to evaluate responsible opioid prescribing and predictors of opioid consumption in immediate implant-based breast reconstruction. Methods: Patients undergoing consultation for immediate, implant-based breast reconstruction were enrolled in a prospective, cohort survey study. A survey was administered at the preoperative and postoperative appointment to collect data on pain expectations and opioid use. A medical record review was performed. Results: Of 100 enrolled patients, 97 (97.0 percent) underwent surgery and 85 (85.0 percent) completed the postoperative survey. Preoperatively, 27 patients (27.0 percent) had a history of a chronic pain syndrome, 34 (34.0 percent) had a history of a mental health comorbidity, and nine (9.0 percent) had a history of active preoperative opioid use. A total of 85 tissue expander (87.6 percent) and 12 direct-to-implant (12.4 percent) reconstructions were completed. Patients were prescribed an average of 36.0 5-mg oxycodone tablets postoperatively. Patients reported consuming an average of 20.6 tablets, or 57.0 percent of the average prescription amount. The majority of patients (75.3 percent) reported taking an opioid less than once per day at the time of survey completion, and 24 patients (28.2 percent) reported that they did not use any opioids postoperatively. Preoperative opioid use (p= 0.004), inpatient opioid consumption (p< 0.0001), and patient-reported anxiety related to pain control (p< 0.05) were predictors of opioid consumption. Conclusions: Patients undergoing mastectomy and implant-based breast reconstruction are prescribed nearly twice as many opioid tablets as consumed, and one in three patients report not using any opioids postoperatively. Clinical factors may help guide prescribing practices.
- 1 September 2020
- Published by Hindawi Limited in The Breast Journal
- Vol. 26 (9) , 1712-1716
Perception of pain and influences on opioid use in implant-based breast reconstruction patients
Although there has been a recent focus on decreasing opioid prescribing through alternative pain medication protocols, the patient's perception of pain related to breast reconstructive surgeries has not been well described. We sought to evaluate patient perception of pain control as it influences opioid use. We hypothesize that modifiable factors may influence patterns in pain perception and postoperative opioid use. Patients undergoing consultation for mastectomy with immediate, implant-based breast reconstruction were enrolled in a prospective, cohort survey study. A survey was administered at preoperative and postoperative appointments to collect data on pain expectations and pain control. Of 100 patients enrolled, 85% completed the postoperative survey. Over half of patients (52%) reported feeling anxious about pain control after surgery. Patients with preoperative opioid use were more likely to expect complete relief of pain postoperatively (P = .038). Patients with psychiatric comorbidity were more likely to report feeling anxious about postoperative pain (P = .012; 70% vs 42%; OR 3.0 CI 1.2-7.4). Patients who reported feeling anxious about pain control preoperatively were more likely to report trying opioids (P = .047; 67% vs 44%; OR 2.5 CI 1.0-6.1) and benzodiazepines (P = .020; 80% vs 56%; OR 3.0 CI 1.2-8.0) postoperatively. Anxiety related to pain control is common and results in an increased likelihood of trying opioid and benzodiazepine medications postoperatively. This presents an opportunity to educate patients preoperatively by addressing anxiety related to pain control to decrease controlled substance use.
- 1 September 2020
- Published by Hindawi Limited in The Breast Journal
- Vol. 26 (9) , 1712-1716
Perception of pain and influences on opioid use in implant-based breast reconstruction patients
Although there has been a recent focus on decreasing opioid prescribing through alternative pain medication protocols, the patient's perception of pain related to breast reconstructive surgeries has not been well described. We sought to evaluate patient perception of pain control as it influences opioid use. We hypothesize that modifiable factors may influence patterns in pain perception and postoperative opioid use. Patients undergoing consultation for mastectomy with immediate, implant-based breast reconstruction were enrolled in a prospective, cohort survey study. A survey was administered at preoperative and postoperative appointments to collect data on pain expectations and pain control. Of 100 patients enrolled, 85% completed the postoperative survey. Over half of patients (52%) reported feeling anxious about pain control after surgery. Patients with preoperative opioid use were more likely to expect complete relief of pain postoperatively (P = .038). Patients with psychiatric comorbidity were more likely to report feeling anxious about postoperative pain (P = .012; 70% vs 42%; OR 3.0 CI 1.2-7.4). Patients who reported feeling anxious about pain control preoperatively were more likely to report trying opioids (P = .047; 67% vs 44%; OR 2.5 CI 1.0-6.1) and benzodiazepines (P = .020; 80% vs 56%; OR 3.0 CI 1.2-8.0) postoperatively. Anxiety related to pain control is common and results in an increased likelihood of trying opioid and benzodiazepine medications postoperatively. This presents an opportunity to educate patients preoperatively by addressing anxiety related to pain control to decrease controlled substance use.
- 13 April 2020
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 27 (9) , 3156-3162
Opioid Consumption Following Breast Surgery Decreases with a Brief Educational Intervention: A Randomized, Controlled Trial
Current rates of opioid prescribing and consumption in the United States have resulted in deleterious consequences for both patients and society. There has
- 13 April 2020
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 27 (9) , 3156-3162
Opioid Consumption Following Breast Surgery Decreases with a Brief Educational Intervention: A Randomized, Controlled Trial
Current rates of opioid prescribing and consumption in the United States have resulted in deleterious consequences for both patients and society. There has
- Open Access
- 1 March 2015
- Published by Wolters Kluwer Health in Plastic and Reconstructive Surgery - Global Open
- Vol. 3 (3) , e361
Mentoring and Modeling Professionalism
- 1 March 2015
- Published by Wolters Kluwer Health in Plastic and Reconstructive Surgery - Global Open
- Vol. 3 (3) , e361
Open AccessMentoring and Modeling Professionalism